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Results of a pre-pilot study of potential test material for the external quality 
assessment of reticulocyte haemoglobin content 
Sir, 
The increasing sophistication of automated red cell analysis has led to the routine 
availability of new measures shown to have clinical utility in the assessment of iron 
status. Of these, reticulocyte haemoglobin content (RHC) has shown considerable 
promise [1,2], as it is at the reticulocyte stage of development that clinically important 
fluctuations in cellular measures of functional iron status are first seen. RHC has 
recently been recommended as a measure of choice in the diagnosis and management 
of iron deficiency in patients with chronic renal failure (3) creating a need for external 
assessment of laboratory performance. We report here the results of a pre-pilot study 
to assess the suitability of material for potential use in such a scheme with instruments 
available in the UK capable of providing this measure. 
Four samples were produced by the UK National External Quality Assessment Scheme 
for Haematology (UK NEQAS(H)). Two (RH2 and RH4) were derived from a single 
donation from a healthy donor taken into citrate-phosphate-dextrose anticoagulant 
and supplied by National Health Service Blood and Transplant. The other two (RH1 and 
RH3) were obtained with informed consent from patients with iron-deficient primary 
polycythaemia treated by venesection and taken into acid-citrate-dextrose 
anticoagulant. All donations were processed according to the protocol used for the 
production of samples in the UK NEQAS(H) full blood count scheme. Five aliquots of 
each sample, labelled ‘Day 1’ – ‘Day 5’ and each containing sufficient material for 10 
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analyses, were issued to six volunteer laboratories together with an instruction sheet 
giving guidance on sample analysis. In order for analysis to take place over five 
consecutive working days, donations were collected six days beforehand and 
processed and despatched the following day in order to arrive at the volunteer 
laboratories before the weekend prior to the commencement of the trial. The 
volunteer laboratories comprised two users each of Abbott, Siemens and Sysmex 
instruments. 
Mean (SD) RHC and reticulocyte percent values were obtained for each sample on 
each instrument over five consecutive days during August 2013. One Sysmex user 
requested additional samples and analysed them on two instruments.  Bartlett’s test 
was used to investigate differences in between-day precision and one-way analysis of 
variance to investigate differences in between-day mean values for samples analysed 
on each instrument. To allow for multiple comparisons only p values <0.001 were 
considered statistically significant. Findings for RHC (pg; reported as MCHr with Abbott, 
CHr with Siemens and Ret-He with Sysmex instruments) are shown in the Table. With 
Abbott instruments statistically significant differences in between-day precision were 
found for five of the eight sets of data. Between-day mean values differed significantly 
in all eight data sets, with daily mean values differing by ≥2pg in six.  There were fewer 
statistically significant differences with Siemens and Sysmex instruments. 
Reticulocyte percent values showed acceptable between-day precision for all samples 
and for all instruments, with no statistically significant findings. There were a few 
statistically significant differences for between-day mean values with both Abbott and 
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Sysmex instruments, although differences were small: with Abbott instruments the 
greatest difference between highest and lowest mean values over the five days was 
0.28% (sample RH4 and Abbot 2), whilst with Sysmex instruments the comparable 
difference was 0.21% (sample RH3 and Sysmex 1). Daily mean values across all four 
samples and both makes of instrument ranged from 0.57-1.96%. Similar results were 
obtained with Siemens instruments on samples from a single donation (RH2 and RH4), 
whilst with the iron-deficient samples (RH1 and RH3) mean values were higher and 
increased significantly over the trial period for both instruments, from 3.92-5.67% and 
4.33-6.37% with RH1 and 2.58-3.40% and 3.06-3.94% with RH2.     
A suitable material for external quality assurance of RHC must permit the stable and 
precise measurement of this variable, by the detection of reticulocytes and their 
segregation from mature red cells. Our findings with three differing models of Sysmex 
instruments were satisfactory both in terms of reticulocyte percent and RHC; a 
statistically significant increase with time in the latter was seen with the iron-deficient 
samples RH1 and RH3 in five of six data sets although daily means differed by <1pg in 
all. Siemens instruments also produced generally stable and precise RHC results with a 
slight decrease in values over time with most samples. Where statistically significant 
differences in between-day mean values occurred they appeared to be mainly a 
consequence of slight but non-overlapping differences between highly precise within-
day estimates. These findings occurred despite significant increases in reticulocyte 
percent values with time in the two iron-deficient samples RH1 and RH3. With Abbott 
instruments, despite the finding of stable and precise reticulocyte percent values, 
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there was a high degree of both statistically significant imprecision and between-day 
variation in means in RHC values. 
Overall these findings indicate stabilised red cells processed in an identical manner to 
those used for routine UK NEQAS(H) blood count trials are suitable for use in external 
quality assessment of RHC with both Siemens and Sysmex instruments. Findings with 
Abbott instruments were less satisfactory and it would be prudent to repeat the study 
with other Abbott users to determine whether a genuine incompatibility exists 
between Abbott technology and the types of sample used in this study. It is the 
intention of UK NEQAS(H) to take forward the work reported here to the pilot study 
stage, to assess the feasibility of providing external quality assessment of reticulocyte 
haemoglobin content. 
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Table. Daily mean (SD) reticulocyte haemoglobin content (pg) values from Abbott Sapphire instruments, Siemens Advia 120 instruments 
and Sysmex instruments (1, XN1000; 2, XE5000; 3, XE2100). ≠; no results available. a,b,c; data based on 8, 9 and 4 replicate analyses 
respectively. Statistically significant differences (p<0.001) in # between-day precision and ¶ between-day values respectively. 
Sample & Day Abbott 1 MCHr 
 MCH 
Abbott 2 MCHr Siemens 1 CHr Siemens 2 CHr Sysmex 1 Ret-He Sysmex 2 Ret-He Sysmex 3 Ret-He 
RH 1 Day 1 22.2 (0.11)#¶ 22.4 (0.45)#¶ 23.5 (0.08)¶ 23.6 (0.10)¶ 25.2 (0.16)¶ 24.9 (0.30) 23.7 (0.34)¶ 
Day 2 20.9 (0.44) 23.0 (0.90) 23.3 (0.07) ≠ 
 
25.6 (0.16) 25.0 (0.36) 23.9 (0.25) 
Day 3 22.5 (0.63) 25.2 (1.14) 23.1 (0.12) 23.1 (0.11) 25.8 (0.23) 25.1 (0.32) 24.4 (0.49) 
Day 4 22.2 (0.94) 25.5 (1.90) 23.1 (0.10) 23.2 (0.05) 25.8 (0.11) 25.1 (0.40) 24.5 (0.39) 
Day 5 20.4 (0.28) 22.6 (0.41) 22.9 (0.08) 23.0 (0.10) 26.1 (0.29) 25.5 (0.30) 24.6 (0.39) 
RH2 Day 1 28.8 (0.11)¶ 28.8 (0.53)#¶ 30.5 (0.16)¶ 30.2 (0.10)¶ 32.0 (0.27) 31.2 (0.70) 30.7 (0.33) 
Day 2 27.0 (0.20) 30.1 (0.87) 30.4 (0.25) ≠ 31.8 (0.15) 31.5 (0.61) 30.5 (0.65) 
Day 3 29.1 (0.21) 31.4 (0.66) 30.3 (0.19) 29.8 (0.22) 31.8 (0.34) 30.9 (0.37) 30.2 (0.36) 
Day 4 28.7 (0.57) 31.2 (0.60) 30.1 (0.27) 30.2 (0.14) 31.8 (0.36) 31.0 (0.59) 30.6 (0.59) 
Day 5 26.7 (0.47) 29.4 (0.27) 30.1 (0.22) 29.8 (0.17) 32.0 (0.35) 31.0 (0.89) 30.3 (0.52) 
RH3 Day 1 23.6 (0.15)#¶ 24.1 (0.29)¶ 25.6 (0.14) 25.2 (0.14)¶ 27.3 (0.16)¶ 26.4 (0.35)¶ 25.9 (0.24)¶ 
Day 2 22.5 (0.31) 25.7 (1.13) 25.6 (0.11) ≠ 27.4 (0.22) 26.6 (0.28) 26.1 (0.32) 
Day 3 24.0 (0.20) 25.7 (0.89) 25.7 (0.11) 25.5 (0.13) 27.6 (0.24) 26.7 (0.28) 26.1 (0.29) 
Day 4 23.5 (0.45) 25.6 (0.82) 25.6 (0.18) 25.9 (0.09) 27.7 (0.12) 26.8 (0.23) 26.8 (0.33) 
Day 5 22.0 (0.40) 24.1 (0.28) 25.7 (0.07) 25.6 (0.13) 28.0 (0.25) 27.3 (0.24) 26.6 (0.35) 
RH4 Day 1 28.1 (0.47)a#¶ 29.2 (0.28)¶ 30.4 (0.18)¶ 30.1 (0.77)# 31.8 (0.25) 31.1 (0.62) 30.5 (0.49) 
Day 2 27.0 (0.30) 31.3 (1.15) 30.4 (0.18) 30.2 (0.20)b 31.8 (0.35) 31.0 (0.68) 30.7 (0.43) 
Day 3 29.0 (0.30) 30.5 (1.15) 30.2 (0.20) 29.7 (0.13)c 31.7 (0.41) 30.9 (0.48) 30.5 (0.52) 
Day 4 28.5 (0.68) 30.6 (0.79) 30.2 (0.16) 30.3 (0.15) 31.8 (0.24) 31.6 (0.47) 30.5 (0.57) 
Day 5 26.8 (0.51) 29.4 (0.20) 30.2 (0.14) 29.8 (0.12) 31.9 (0.37) 31.5 (0.51) 30.4 (0.54) 
 
